HUP0101587A2 - Antagonista vegyületek CD11/CD18 adhéziós receptor közvetítette betegségek kezelésére - Google Patents
Antagonista vegyületek CD11/CD18 adhéziós receptor közvetítette betegségek kezeléséreInfo
- Publication number
- HUP0101587A2 HUP0101587A2 HU0101587A HUP0101587A HUP0101587A2 HU P0101587 A2 HUP0101587 A2 HU P0101587A2 HU 0101587 A HU0101587 A HU 0101587A HU P0101587 A HUP0101587 A HU P0101587A HU P0101587 A2 HUP0101587 A2 HU P0101587A2
- Authority
- HU
- Hungary
- Prior art keywords
- treatment
- antagonists
- adhesion receptor
- receptor mediated
- mediated disorders
- Prior art date
Links
- 239000005557 antagonist Substances 0.000 title abstract 3
- 230000001404 mediated effect Effects 0.000 title abstract 3
- 102000019997 adhesion receptor Human genes 0.000 title 1
- 108010013985 adhesion receptor Proteins 0.000 title 1
- 102100025390 Integrin beta-2 Human genes 0.000 abstract 4
- 101000935040 Homo sapiens Integrin beta-2 Proteins 0.000 abstract 3
- 241000124008 Mammalia Species 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 101100289995 Caenorhabditis elegans mac-1 gene Proteins 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 108010064548 Lymphocyte Function-Associated Antigen-1 Proteins 0.000 abstract 1
- 230000003042 antagnostic effect Effects 0.000 abstract 1
- 230000001413 cellular effect Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 230000008105 immune reaction Effects 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/559—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing hetero atoms other than oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4458—Non condensed piperidines, e.g. piperocaine only substituted in position 2, e.g. methylphenidate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4192—1,2,3-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Furan Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Hydrogenated Pyridines (AREA)
- Pyrrole Compounds (AREA)
Abstract
A találmány tárgyát képezik az (I) általános képletű antagonistavegyületek amelyek a CD11/CD18 adhéziós receptorcsalád antagonistái,és különösen alkalmasak CD11/CD18 receptorok (elsősorban (Mac-1 ésLFA-1 receptorok) által közvetített rendellenességek emlősökben(elsősorban emberekben) történő kezelésére. Szintén a találmánytárgyát képezi a találmány szerinti antagonista vegyületek alkalmazása- emlősökben CD11/CD18 celluláris adhéziós molekulacsalád általközvetített immun- vagy gyulladásos reakció vagy rendellenességkezelésére vagy enyhítésére alkalmas - gyógyászati készítményelőállítására. Ó
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7973298P | 1998-03-27 | 1998-03-27 | |
PCT/US1999/006410 WO1999049856A2 (en) | 1998-03-27 | 1999-03-24 | Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0101587A2 true HUP0101587A2 (hu) | 2001-08-28 |
HUP0101587A3 HUP0101587A3 (en) | 2003-03-28 |
Family
ID=22152446
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0101587A HUP0101587A3 (en) | 1998-03-27 | 1999-03-24 | Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders |
Country Status (19)
Country | Link |
---|---|
US (1) | US20050203135A1 (hu) |
EP (1) | EP1063982B1 (hu) |
JP (2) | JP2002509881A (hu) |
KR (1) | KR100596109B1 (hu) |
CN (1) | CN1191063C (hu) |
AT (1) | ATE353640T1 (hu) |
AU (1) | AU764524B2 (hu) |
BR (1) | BR9909418A (hu) |
CA (1) | CA2325986A1 (hu) |
DE (1) | DE69935133T2 (hu) |
EA (1) | EA007852B1 (hu) |
HU (1) | HUP0101587A3 (hu) |
IL (2) | IL138297A0 (hu) |
NO (1) | NO20004800L (hu) |
NZ (1) | NZ506779A (hu) |
PL (1) | PL343555A1 (hu) |
UA (1) | UA74531C2 (hu) |
WO (1) | WO1999049856A2 (hu) |
ZA (1) | ZA200004653B (hu) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6331640B1 (en) | 1998-10-13 | 2001-12-18 | Hoffmann-La Roche Inc. | Diaminopropionic acid derivatives |
US6110922A (en) | 1998-12-29 | 2000-08-29 | Abbott Laboratories | Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
US6878700B1 (en) | 1998-12-29 | 2005-04-12 | Abbott Laboratories | Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
WO2001007044A1 (en) | 1999-07-21 | 2001-02-01 | Boehringer Ingelheim Pharmaceuticals, Inc. | Small molecules useful in the treatment of inflammatory disease |
US6492408B1 (en) | 1999-07-21 | 2002-12-10 | Boehringer Ingelheim Pharmaceuticals, Inc. | Small molecules useful in the treatment of inflammatory disease |
ATE396722T1 (de) | 1999-07-21 | 2008-06-15 | Boehringer Ingelheim Pharma | Kleine moleküle zur behandlung von endzündlichen erkrankungen |
WO2001007052A1 (en) | 1999-07-21 | 2001-02-01 | Boehringer Ingelheim Pharmaceuticals, Inc. | Small molecules useful in the treatment of inflammatory disease |
KR100720907B1 (ko) * | 1999-08-13 | 2007-05-25 | 바이오겐 아이덱 엠에이 인코포레이티드 | 세포 유착 억제제 |
US6515124B2 (en) | 2000-02-09 | 2003-02-04 | Hoffman-La Roche Inc. | Dehydroamino acids |
EP1276713A4 (en) * | 2000-03-27 | 2006-05-03 | Scripps Research Inst | INHIBITION OF ANGIOGENESIS AND TUMOR GROWTH |
EP1294704A1 (en) | 2000-06-29 | 2003-03-26 | Abbott Laboratories | Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
US6521619B2 (en) | 2000-06-29 | 2003-02-18 | Icos Corporation | Aryl phenylcyclopropyl sulfide derivatives and their use as cell adhesion inhibiting anti-inflammatory and immune suppressive agents |
AU2002248142B2 (en) | 2000-11-28 | 2007-11-01 | Genentech, Inc. | LFA-1 antagonist compounds |
PL374971A1 (en) * | 2002-08-09 | 2005-11-14 | Transtech Pharma, Inc. | Aryl and heteroaryl compounds and methods to modulate coagulation |
WO2004032861A2 (en) | 2002-10-11 | 2004-04-22 | Bristol-Myers Squibb Company | Hexahydro-benzimidazolone compounds useful as anti-inflammatory agents |
CA2520763A1 (en) | 2003-04-03 | 2004-10-21 | The Regents Of The University Of California | Improved inhibitors for the soluble epoxide hydrolase |
US7208601B2 (en) * | 2003-08-08 | 2007-04-24 | Mjalli Adnan M M | Aryl and heteroaryl compounds, compositions, and methods of use |
US7501538B2 (en) * | 2003-08-08 | 2009-03-10 | Transtech Pharma, Inc. | Aryl and heteroaryl compounds, compositions and methods of use |
US7920906B2 (en) | 2005-03-10 | 2011-04-05 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US7199125B2 (en) | 2003-10-02 | 2007-04-03 | Bristol-Myers Squibb Company | Spiro-cyclic compounds useful as anti-inflammatory agents |
CN105820160B (zh) | 2003-11-05 | 2019-02-12 | 萨可德生物科学公司 | 细胞粘着调节剂 |
US9247900B2 (en) | 2004-07-13 | 2016-02-02 | Dexcom, Inc. | Analyte sensor |
JP2007532484A (ja) | 2004-03-16 | 2007-11-15 | ザ・レジェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア | 可溶性エポキシド加水分解酵素の阻害剤およびエポキシエイコサノイドを用いて腎症を緩和する方法 |
US20060020192A1 (en) | 2004-07-13 | 2006-01-26 | Dexcom, Inc. | Transcutaneous analyte sensor |
WO2006127694A2 (en) | 2004-07-13 | 2006-11-30 | Dexcom, Inc. | Analyte sensor |
US7375237B2 (en) | 2004-08-18 | 2008-05-20 | Bristol-Myers Squibb Company | Pyrrolizine compounds useful as anti-inflammatory agents |
TW200616634A (en) | 2004-10-01 | 2006-06-01 | Bristol Myers Squibb Co | Crystalline forms and process for preparing spiro-hydantoin compounds |
EP1814875A4 (en) * | 2004-10-20 | 2010-02-17 | Univ California | IMPROVED INHIBITORS OF SOLUBLE HYDROLASE EPOXYDE |
US7186727B2 (en) | 2004-12-14 | 2007-03-06 | Bristol-Myers Squibb Company | Pyridyl-substituted spiro-hydantoin compounds and use thereof |
PT1881823E (pt) | 2005-05-17 | 2015-03-02 | Sarcode Bioscience Inc | Composições e métodos para o tratamento de transtornos oculares |
EP2020992A2 (en) * | 2006-04-24 | 2009-02-11 | The CBR Institute for Biomedical Research, Inc. | Method of producing immunoliposomes and compositions thereof |
US20130129752A1 (en) * | 2006-04-25 | 2013-05-23 | Immune Disease Institute, Inc. | Targeted delivery to leukocytes using protein carriers |
ES2830024T3 (es) | 2007-10-19 | 2021-06-02 | Novartis Ag | Composiciones y métodos para el tratamiento del edema macular |
BRPI0819831A2 (pt) | 2007-11-29 | 2019-09-24 | Boehringer Ingelheim Int | derivados de amidas de áciodo 6,7-diidro-5h-imidazo[1,2-a]imidazol-3-carboxílico |
CN102065893A (zh) * | 2008-04-15 | 2011-05-18 | 萨可德公司 | Lfa-1拮抗剂向胃肠***的递送 |
EP3632444A3 (en) | 2008-04-15 | 2020-08-26 | SARcode Bioscience Inc. | Topical lfa-1 antagonists for use in localized treatment of immune related disorders |
US8080562B2 (en) | 2008-04-15 | 2011-12-20 | Sarcode Bioscience Inc. | Crystalline pharmaceutical and methods of preparation and use thereof |
CN102083432B (zh) | 2008-05-05 | 2016-02-17 | 赛诺菲-安万特 | 酰基氨基取代的稠合环戊烷羧酸衍生物及它们作为药物的用途 |
WO2010058730A1 (ja) | 2008-11-19 | 2010-05-27 | ポーラ化成工業株式会社 | シワ改善剤 |
NZ595622A (en) | 2009-06-02 | 2014-02-28 | Boehringer Ingelheim Int | Derivatives of 6,7-dihydro-5h-imidazo[1,2-a]imidazole-3-carboxylic acid amides |
WO2010141330A1 (en) | 2009-06-02 | 2010-12-09 | Boehringer Ingelheim International Gmbh | DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-a]IMIDAZOLE-3-CARBOXYLIC ACID AMIDES |
US8378105B2 (en) | 2009-10-21 | 2013-02-19 | Sarcode Bioscience Inc. | Crystalline pharmaceutical and methods of preparation and use thereof |
AR079022A1 (es) | 2009-11-02 | 2011-12-21 | Sanofi Aventis | Derivados de acido carboxilico ciclico sustituidos con acilamino, su uso como productos farmaceuticos, composicion farmaceutica y metodo de preparacion |
US8404859B2 (en) | 2011-03-16 | 2013-03-26 | Hoffmann-La Roche Inc. | Thiazole and thiophene compounds |
CN103420917B (zh) * | 2012-05-18 | 2015-08-19 | 国药一心制药有限公司 | 含稠环结构的苯甲酰胺类化合物及其作为抗肿瘤药物应用 |
KR20200108932A (ko) | 2012-07-25 | 2020-09-21 | 에스에이알코드 바이오사이언스 인코포레이티드 | Lfa-1 저해제 및 그의 다형체 |
FR3019901B1 (fr) | 2014-04-09 | 2020-10-30 | Bio Rad Innovations | Marqueur de controle pour la mise en oeuvre de procedes d'analyse sur spots |
WO2017102014A1 (en) * | 2015-12-17 | 2017-06-22 | Universite D'aix-Marseille | Propenamide thiophene derivatives as flavivirus inhibitors and their use |
CN107987105B (zh) * | 2017-11-24 | 2019-10-01 | 无锡微色谱生物科技有限公司 | 一种可用于皮肤敷料的h2s给体化合物、海绵敷料和制备方法 |
CN115348861A (zh) | 2019-12-10 | 2022-11-15 | 加利福尼亚大学董事会 | α-5 β-1抑制剂 |
WO2023204330A1 (ko) * | 2022-04-22 | 2023-10-26 | 트윈피그바이오랩(주) | Itgb2 매개 약물 전달시스템 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1182518A (en) * | 1968-11-01 | 1970-02-25 | Parke Davis & Co | Novel Dibasic Acid Compounds and Means for the Production Thereof |
US4314988A (en) * | 1979-10-31 | 1982-02-09 | Baker Instruments Corp. | Folic acid derivatives and process for preparation |
US4871743A (en) * | 1988-01-19 | 1989-10-03 | The Trustees Of Princeton University | L-glutamic acid derivatives |
US5013738A (en) * | 1990-04-18 | 1991-05-07 | The Trustees Of Princeton University | L-glutamic acid derivatives |
ATE147386T1 (de) * | 1991-08-12 | 1997-01-15 | Takeda Chemical Industries Ltd | Kondensierte pyrimidinderivate, ihre herstellung und ihre verwendung als antitumormittel |
JPH05306226A (ja) * | 1992-04-27 | 1993-11-19 | Takeda Chem Ind Ltd | 慢性免疫疾患治療剤 |
CA2151588C (en) * | 1992-12-16 | 2002-03-19 | Michael D. Varney | Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone |
EP1304322A3 (en) * | 1995-08-22 | 2003-11-19 | Japan Tobacco Inc. | Carboxylic acid compound and use thereof |
TR200000482T2 (tr) * | 1997-08-22 | 2000-06-21 | F. Hoffmann-La Roche Ag. | N-Aroilfenilalanin türevleri. |
AU1411499A (en) * | 1997-11-20 | 1999-06-15 | Merck & Co., Inc. | Para-aminomethylaryl carboxamide derivatives |
MY153569A (en) * | 1998-01-20 | 2015-02-27 | Mitsubishi Tanabe Pharma Corp | Inhibitors of ?4 mediated cell adhesion |
-
1999
- 1999-03-24 EP EP99912869A patent/EP1063982B1/en not_active Expired - Lifetime
- 1999-03-24 IL IL13829799A patent/IL138297A0/xx not_active IP Right Cessation
- 1999-03-24 JP JP2000540822A patent/JP2002509881A/ja not_active Withdrawn
- 1999-03-24 AU AU31137/99A patent/AU764524B2/en not_active Ceased
- 1999-03-24 PL PL99343555A patent/PL343555A1/xx not_active Application Discontinuation
- 1999-03-24 CN CNB998043753A patent/CN1191063C/zh not_active Expired - Fee Related
- 1999-03-24 CA CA002325986A patent/CA2325986A1/en not_active Abandoned
- 1999-03-24 HU HU0101587A patent/HUP0101587A3/hu unknown
- 1999-03-24 NZ NZ506779A patent/NZ506779A/en unknown
- 1999-03-24 KR KR1020007010720A patent/KR100596109B1/ko not_active IP Right Cessation
- 1999-03-24 WO PCT/US1999/006410 patent/WO1999049856A2/en active IP Right Grant
- 1999-03-24 UA UA2000106027A patent/UA74531C2/uk unknown
- 1999-03-24 AT AT99912869T patent/ATE353640T1/de not_active IP Right Cessation
- 1999-03-24 DE DE69935133T patent/DE69935133T2/de not_active Expired - Fee Related
- 1999-03-24 BR BR9909418-5A patent/BR9909418A/pt not_active Application Discontinuation
- 1999-03-24 EA EA200000985A patent/EA007852B1/ru not_active IP Right Cessation
-
2000
- 2000-09-05 ZA ZA200004653A patent/ZA200004653B/en unknown
- 2000-09-06 IL IL138297A patent/IL138297A/en unknown
- 2000-09-26 NO NO20004800A patent/NO20004800L/no not_active Application Discontinuation
-
2003
- 2003-08-26 US US10/649,762 patent/US20050203135A1/en not_active Abandoned
-
2007
- 2007-04-09 JP JP2007101875A patent/JP2007224037A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
NO20004800D0 (no) | 2000-09-26 |
DE69935133D1 (de) | 2007-03-29 |
KR20010034708A (ko) | 2001-04-25 |
EA200000985A1 (ru) | 2001-06-25 |
CN1295471A (zh) | 2001-05-16 |
CA2325986A1 (en) | 1999-10-07 |
IL138297A0 (en) | 2001-10-31 |
PL343555A1 (en) | 2001-08-27 |
WO1999049856A3 (en) | 1999-11-18 |
CN1191063C (zh) | 2005-03-02 |
EP1063982A2 (en) | 2001-01-03 |
AU3113799A (en) | 1999-10-18 |
KR100596109B1 (ko) | 2006-07-05 |
JP2007224037A (ja) | 2007-09-06 |
AU764524B2 (en) | 2003-08-21 |
WO1999049856A2 (en) | 1999-10-07 |
ATE353640T1 (de) | 2007-03-15 |
HUP0101587A3 (en) | 2003-03-28 |
ZA200004653B (en) | 2002-02-27 |
EA007852B1 (ru) | 2007-02-27 |
EP1063982B1 (en) | 2007-02-14 |
NZ506779A (en) | 2003-08-29 |
US20050203135A1 (en) | 2005-09-15 |
JP2002509881A (ja) | 2002-04-02 |
IL138297A (en) | 2006-06-11 |
BR9909418A (pt) | 2001-09-25 |
DE69935133T2 (de) | 2007-11-22 |
UA74531C2 (en) | 2006-01-16 |
NO20004800L (no) | 2000-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0101587A2 (hu) | Antagonista vegyületek CD11/CD18 adhéziós receptor közvetítette betegségek kezelésére | |
ATE384050T1 (de) | Benzazepinderivate als histamin-h3-antagonisten | |
CY1110882T1 (el) | Ανταγωνιστες υποδοχεων ορεξινης υποκατεστημενης διαζεπανης | |
CR9389A (es) | Compuestos de imidazopiridazina | |
EA200200646A1 (ru) | Соединения мочевины, обладающие активностью антагонистов мускариновых рецепторов | |
WO2004082605A3 (en) | Bicyclic anilide spirohydantoin cgrp receptor antagonists | |
MX2009005712A (es) | Antagonistas de receptor de orexina de diazepam sustituido. | |
ATE423769T1 (de) | Fluor- und sulfonylaminohaltige, 3,6- disubstituierte azabicyclo 3.1.0 hexanderivate als muscarinrezeptorantagonisten | |
WO2007061763A3 (en) | Indole orexin receptor antagonists | |
ATE516803T1 (de) | Aryl-spirohydantoin-cgrp-rezeptor-antagonisten | |
WO2007025069A3 (en) | Diazaspirodecane orexin receptor antagonists | |
CY1112505T1 (el) | Ανοσοκατασταλτικες ενωσεις και συνθεσεις | |
WO2008008517A3 (en) | Bridged diazepan orexin receptor antagonists | |
UA89192C2 (ru) | Производные пиролопиримидина и пиролопиридина, замещенные циклической аминогруппой, как антагонисты crf | |
BRPI0411131A (pt) | composto, método de tratar uma doença mediada pelo receptor de canabinóide 1, método de previnir a obesidade de uma pessoa com risco de obesidade, composição, e, uso de um composto | |
WO2007126935A3 (en) | Diazepan orexin receptor antagonists | |
HRP20050556B1 (hr) | Supstituirani derivati 1-piperidin-4-il-4-pirolidin-3-il-piperazina i njihova upotreba kao antagonista receptora za neurokinin | |
MXPA04000372A (es) | Compuesto biciclicos de heteroarilo fusionados sustituidos con heteroarilo como ligandos del receptor gabaa. | |
WO2006052962A3 (en) | Bicyclic triazole a4 integrin inhibitors | |
WO2004087649A3 (en) | Benodiazepine spirohydantoin cgrp receptor antagonists | |
ATE518852T1 (de) | Tricyclische anilid-spirohydantoin-cgrp- rezeptorantagonisten | |
PL1648925T3 (pl) | Środki obrazujące na bazie bicyklicznych peptydów | |
UA100974C2 (ru) | Соединения замещенных диазепанов как антагонисты орексиновых рецепторов | |
WO2007019234A3 (en) | Aminoethane sulfonamide orexin receptor antagonists | |
EA200500172A1 (ru) | Азабициклопроизводные в качестве антагонистов мускариновых рецепторов |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD9A | Lapse of provisional protection due to non-payment of fees |